PB-127

N/A

Report date: 2022/11/25 17:24:33

Base Information

Drug NamePB-127
Drug Alias NameCardioSpherePBC-127PB-127
ClassificationDiagnostic agent (In vivo)Small molecules
Mechanisms of ActionUltrasonography enhancers
TargetsNot applicable
Therapy Area/IndicationsCoronary Artery Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPoint Biomedical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPoint Biomedical Corp
Active IndicationsN/A
Inactive IndicationsCoronary Artery Disease

Other Information

ATC CodeN/A
Related LinksN/A